Skin and hypersensitivity reaction News Digital Network Ustekinumab Re-treatment Delivers Excellent Results Skin and Allergy tidings Digital Network LISBON – Roughly 85% of disease of the skin patients re-treated with ustekinumab after withdrawing from AN earlier successful course of therapy will experience AN excellent response in circular two. This benefit was consistently seen in alternate analyses of two ... Link To Article
No comments:
Post a Comment